Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.
Research output: Contribution to journal › Article
Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Publication status||Published - 2014|
No data available
Related research output
Siker Kimbung, 2014, Oncology, MV. 152 p.
Research output: Thesis › Doctoral Thesis (compilation)